PERIOPERATIVE CHEMOTHERAPY WITH FOLFOX IN RESECTABLE GASTRO-OESOPHAGEAL ADENOCARCINOMA: AN AGEO MULTICENTRIC RETROSPECTIVE STUDY

被引：0

作者：

Florence, Mary ^{[1
]}

Aziz, Zaanan ^{[2
]}

David, Malka ^{[3
]}

Pascal, Artru ^{[4
]}

Marouane, Boubaya ^{[1
]}

Emmanuelle, Samalin ^{[5
]}

Romain, Coriat ^{[6
]}

Baptiste, Bachet Jean ^{[7
]}

David, Tougeron ^{[8
]}

Mourad, Benallaoua ^{[1
]}

Pauline, Afchain ^{[9
]}

Christophe, Locher ^{[10
]}

Isabelle, Baumgaertner ^{[11
]}

Cedric, Lecaille ^{[12
]}

Thomas, Aparicio ^{[1
]}

机构：

[1] Hop Avicenne, F-93009 Bobigny, France

[2] Hop Europeen Georges Pompidou, Paris, France

[3] Inst Gustave Roussy, Villejuif, France

[4] Hop Prive Jean Mermoz, Lyon, France

[5] Ctr Val dAurelle Paul Lamarque, Montpellier, France

[6] Hop Cochin, F-75674 Paris, France

[7] Grp Hosp Pitie Salpetriere, F-75634 Paris, France

[8] CHU Poitiers, Poitiers, France

[9] Hop St Antoine, F-75571 Paris, France

[10] Hop Meaux, Meaux, France

[11] Hop Henri Mondor, F-94010 Creteil, France

[12] Polyclin Bordeaux Nord Aquitine, Boreaux, France

来源：

ANNALS OF ONCOLOGY | 2014年 / 25卷

关键词：

D O I：

10.1093/annonc/mdu165.43

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P - 0047

引用

页码：41 / 41

页数：1

共 50 条

[41] The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction Cancer
Cartwright, Elizabeth
Cunningham, David
[J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (12)
[42] Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux
Rubenstein, J. H.
Taylor, J. B.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (10) : 1222 - 1227
[43] GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) SYMPTOMATOLOGY IS NOT A RELIABLE PREDICTOR OF OESOPHAGEAL ADENOCARCINOMA
Sugumaran, A.
Rasheed, A.
[J]. GUT, 2013, 62 : A194 - A194
[44] Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study
Lembo, T
Ippoliti, AF
Ramers, C
Weinstein, WM
[J]. GUT, 1999, 45 (04) : 484 - 488
[45] CROSS versus modified MAGIC or FLOT in oesophageal and gastro-oesophageal junction adenocarcinoma
van Rossum, Peter S. N.
van Laarhoven, Hanneke W. M.
[J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (11): : 959 - 960
[46] Trastuzumab Deruxtecan: A Review in Gastric or Gastro-Oesophageal Junction Adenocarcinoma
Connie Kang
[J]. Targeted Oncology, 2023, 18 (6) : 981 - 989
[47] Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction
de Manzoni, G
Pedrazzani, C
Pasini, F
Durante, E
Gabbani, M
Grandinetti, A
Guglielmi, A
Griso, C
Cordiano, C
[J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (06): : 506 - 510
[48] Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma
Young, Kate
Smyth, Elizabeth
Chau, Ian
[J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (06): : 373 - 383
[49] A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma
Mirza, A.
Brown, M.
McNulty, C.
Valentine, J.
Annesley, A.
Galloway, S.
Welch, I.
West, C. M.
Pritchard, S.
[J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2013, 2013
[50] Trastuzumab Deruxtecan: A Review in Gastric or Gastro-Oesophageal Junction Adenocarcinoma
Kang, Connie
[J]. TARGETED ONCOLOGY, 2023, 18 (06) : 981 - 989

← 1 2 3 4 5 →